doi:10.3969/j.issn.1673-8640.2017.03.020

Abstract

CLC Number:

R446.5

Figures/Tables 1

References 10

[1]	张晓芸,谭晓燕,李冬丽,等. ICU泛耐药肺炎克雷伯菌肺部感染暴发与控制[J]. 中华医院感染学杂志, 2012,22(1):79-80.
[2]	汪复,朱德姝,胡付品,等. 2008年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志,2009 ,9(5):321-329.
[3]	汤瑾,李卿,蒋燕群. 对肺炎克雷伯菌碳青霉烯酶的研究进展[J]. 检验医学,2010, 25(1):63-66.
[4]	ENDIMIANI A,HUJER A M,PEREZ F,et al.Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA[J]. J Antimicrob Chemother,2009,63(3):427-437.
[5]	王育红,李风学,张志清,等. 24种中药水煎剂与免煎颗粒剂对临床菌株的体外抑菌作用[J]. 江苏中医药,2006,27(4):52-54.
[6]	黄玲,林居纯,马驰,等. 12种中药的体外抑菌试验[J]. 动物医学进展,2010,31(6):50-52.
[7]	陶庆春,田欢栋. 双黄连粉针剂对产ESBLs大肠埃希菌的体外抑菌作用[J]. 中国卫生检验杂志,2010,20(6):1382-1384.
[8]	TEGOS G,STERMITZ F R,LOMOVSKAYA O,et al.Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials[J]. Antimicrob Agents Chemother,2002,46(10):3133-3141.
[9]	曹翠萍,宁海强,位朋,等. 中药与抗菌药物联用对大肠杆菌抑制作用的研究[J]. 西南农业学报,2008,27(1):217-219.
[10]	徐海瑛,王树芳,王丽,等. 双黄连口服液联合庆大霉素的体外抗菌作用研究[J]. 医药导报,2013,32(1):19-22.

双黄连水平（ mg/mL）	头孢哌酮-舒巴坦（μg/mL）
双黄连水平（ mg/mL）	1 024	512	256	128	64	32	16	8
25.0	-	-	-	-	-	-	+	+
20.0	-	-	-	-	-	+	+	+
15.0	-	-	-	+	+	+	+	+
10.0	-	-	+	+	+	+	+	+
5.0	-	+	+	+	+	+	+	+
2.5	-	+	+	+	+	+	+	+
1.0	-	+	+	+	+	+	+	+

双黄连水平（ mg/mL）	头孢哌酮-舒巴坦（μg/mL）
双黄连水平（ mg/mL）	1 024	512	256	128	64	32	16	8
25.0	-	-	-	-	-	-	+	+
20.0	-	-	-	-	-	+	+	+
15.0	-	-	-	+	+	+	+	+
10.0	-	-	+	+	+	+	+	+
5.0	-	+	+	+	+	+	+	+
2.5	-	+	+	+	+	+	+	+
1.0	-	+	+	+	+	+	+	+

[1]	MENG Huimin, YANG Junli, HAN Yongyan. Relationship between differential expression of gut microbiota structure and prognosis in patients with septic shock [J]. Laboratory Medicine, 2025, 40(5): 455-459.
[2]	ZHU Jing, ZHANG Rulin, WU Jun. Expressions of CCNB1，PTTG1 and CBX3 in hepatocellular carcinoma and their roles in prognostic assessment [J]. Laboratory Medicine, 2025, 40(4): 331-337.
[3]	MA Duan. Consideration and application of improving the positive detection rate of rare genetic disorders [J]. Laboratory Medicine, 2025, 40(2): 109-113.
[4]	WANG Guoyu, ZHAI Jianzhao, ZHONG Huiyu, LIU Tangyuheng, JIAO Lin, HE Yong, YING Binwu, WANG Minjin. Clinical phenotype and molecular genetic characteristics of adult Krabbe disease in China [J]. Laboratory Medicine, 2025, 40(2): 121-130.
[5]	LIU Fadi, LE Ping, WU Yinglong, LIU Huihua, YI Ting, FU Jingjing, KE Jiangwei. Sequencing analysis of hearing-impaired children with negative hearing loss gene screening results and carrying only a single heterozygous variant in GJB2 or SLC26A4 [J]. Laboratory Medicine, 2024, 39(12): 1202-1207.
[6]	MA Yan, ZHOU Chunmei, HUANG Shenglei, WANG Beili, PAN Baishen, GUO Wei. Application evaluation of 24 h satellite blood culture to improve pathogenic microorganism culture process in emergency [J]. Laboratory Medicine, 2024, 39(10): 993-998.
[7]	ZHANG Jing. Synergistic role of vitamin D and blood glucose in pregnancy outcomes in patients with preeclampsia [J]. Laboratory Medicine, 2024, 39(8): 779-786.
[8]	YANG Huilin, CHEN Juan, YAN Jinjin, OU Jiawen, WEN Mingming, ZHOU Lina. Analysis of 4 blood culture bottles' adsorption capacity to 4 commonly used antibiotics [J]. Laboratory Medicine, 2024, 39(6): 578-582.
[9]	LI Anqi, ZHANG Shuya, HE Shanna, CHEN Qiaoqiao, LÜ Qi, LÜ Wanfei, LI Chunxian, WANG Weihua, ZHENG Lin. Rapid bacterial identification and drug susceptibility test of blood culture-positive samples [J]. Laboratory Medicine, 2024, 39(3): 243-248.
[10]	CHEN Yu, ZHAO Ya, WANG Lin. Microbial distribution and drug resistance in chronic dacryocystitis [J]. Laboratory Medicine, 2024, 39(3): 256-259.
[11]	. [J]. Laboratory Medicine, 2023, 38(7): 692-695.
[12]	FANG Yongmei, ZHANG Yan, XU Xueying, ZHONG Feng. Correlation of Staphylococcus aureus drug resistance with drug resistance genes and virulence genes [J]. Laboratory Medicine, 2023, 38(4): 357-361.
[13]	LIU Congcong, LI Jiaping, ZHOU Hongwei. Performance evaluation of 2 mass spectrometry systems in clinical microbial identification [J]. Laboratory Medicine, 2022, 37(11): 1084-1088.
[14]	. [J]. Laboratory Medicine, 2022, 37(10): 952-954.
[15]	LI Renqiang, LUO Junfeng, CHEN Yundi. Establishment and evaluation of α-thalassemia and β-thalassemia mutation determinations using hetero-tail dual-labeled fluorescent probe hydridization [J]. Laboratory Medicine, 2022, 37(10): 955-962.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 10

Related Articles 15

Recommended Articles

Metrics